Cancer Treatments

7 Weak spots of cancer and how to take advantage of them
Cancer and pH
Clinical Studies and New Medicines
Coping with side effects
Dealing with Nausea and Vomiting
The Issels Treatment
New Liquid Ionic Cesium Chloride
Stem Cell Research
What are the side effects of radiation therapy?

Clinical Studies & New Medicines

Latest research and treatments for Anaplastic Thyroid Carcinoma (ATC). The following studies are published in The Journal of Clinical Endocrinology & Metabolism and were funded by American Cancer Society.

February 1, 2003
Manumycin and Paclitaxel together help fight Anaplastic Thyroid Carcinoma cells

October 13, 2003
ONYX-015 virus kills Anaplastic Thyroid Carcinoma (ATC) cells
ONYX-015 virus kills anaplastic thyroid carcinoma (ATC) cells and enhances the antineoplastic effects of doxorubicin and paclitaxel. Our results suggest that the combination of ONYX-015 and radiotherapy should be considered for experimental trials in patients with anaplastic thyroid carcinoma.

April 1, 2001
Effect of Manumycin and Paclitaxel against Anaplastic Thyroid Carcinoma
We found that the combination of manumycin and paclitaxel enhanced the antitumor effects of both drugs against ATC. Our previous works have demonstrated that the combination of paclitaxel and manumycin improved their antineoplastic effect against ATC cells. In this paper we present data further showing that the combination of paclitaxel and manumycin provides improved antineoplastic activity in vivo without increased toxicity.


Go back to top

Poly-MVA was invented with the purpose of finding a non-toxic treatment for cancer. Many doctors recommend this nutritional supplement to their patients. Tests in animals and clinical experience in humans have shown that Poly-MVA has anti-cancer qualities. Poly-MVA is widely used in alternative cancer clinics in Mexico and other offshore locations. It has been widely used in the United States, usually under the guidance of a physician. While there have been no clinical trials up to now, there are sufficient reports of cures that trials are warranted. There are no known side affects of Poly-MVA.

Townsend Letter for Doctors and Patients
February/March 2003
The Medical Journalist Report of Innovative Biologics: Cancer Remission Rates Increase from Use of the Safe and Effective Lipoic Acid Palladium Complex Poly-MVA

by Morton Walker, DPM

Poly-MVA: New hope for cancer patients
Wellness Directory of Minnesota
This new chemotherapy has shown promise in reversing all cancers, even multiple myeloma (bone cancer) and pancreatic cancer, however, for brain cancers, this is the first chemotherapy to break the blood brain barrier.

Frequently asked questions about Poly-MVA.

Poly-MVA Doctor Testimonials
Poly-MVA testimonials from doctors.

Ploy-MVA Customer Testimonials
Read these testimonials from patients to find out how Poly-MVA has made a difference in so many lives, especially cancer patients.

Go back to top

The Issels Treatment

An Integrative Approach to Cancer
Josef M. Issels, M.D., developed a Comprehensive Immunotherapy for cancer and achieved complete remission of "incurable cancers" without further recurrence for up to four decades.


Conventional only   Conventional & Issels Treatment        Conventional only   Conventional & Issels Treatment

Go back to top


New Liquid Ionic Cesium Chloride

Cesium Chloride
February 16, 2004

Cesium is one of the most alkaline elements. Otto Warburg won a Nobel prize for showing that cancer thrives in anaerobic (without oxygen), or acidic, conditions. Research by Keith Brewer, PhD and H.E. Satori has shown that raising the pH, or oxygen content, range of a cell to 8.0 creates a deadly environment for cancer. The pH scale ranges from 0 to 14, with numbers below 7 representing an acidic condition and above 7 representing an alkaline, or oxygenated, condition. When cesium is taken up by cancer cells, it raises the pH, or oxygen content, of the cell. The cells that die are absorbed and eliminated by the body.

Please also see Cell Power Drops.

Go back to top

Stem Cell Research

December 8, 2003
Novel gene therapy delivery uses stem cells that target, attack tumors
Genetically engineered stem cells can find tumors and then produce biological killing agents right at the cancer site. Researchers say that this might be the first gene therapy "delivery system" capable of homing in on and then attacking cancer that has metastasized -- wherever it is in a patient's body.

November 25, 2003
Background about stem cell research
Canadian Cancer Society's Web site explains how the latest research can benefit cancer, improvement of gene therapy approaches for cancer treatment, and applications for cancer research.

Go back to top

Home  |  Books  |  Links  |  Survival Stories  |  Contact Us

Disclaimer: The information on this Web site was researched for a family member and is being made available to public only for educational purposes. We neither endorse nor recommend any products, diets, recipes, treatments, or therapies because we are not healthcare experts. Please consult your healthcare expert before trying any treatments or products mentioned on this Web site.